Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 152 No. 1718 (2022)

Occupations and geographical distribution of mesothelioma in Switzerland 1989–2018 – record linkage of an asbestos-exposed population with the Swiss National Cohort

  • Benjamin N. Locher
  • Fabio Barresi
  • Barbara K. Kuhn
  • Bart Vrugt
  • Matthias Bopp
  • Holger Dressel
DOI
https://doi.org/10.4414/SMW.2022.w30164
Cite this as:
Swiss Med Wkly. 2022;152:w30164
Published
01.05.2022

Summary

OBJECTIVE: We investigated the possibility of linking the data of the Swiss Laboratory for Particle Analysis (Silag), a valuable but incomplete data source in the field of asbestos-related diseases, to the Swiss National Cohort (SNC). With the resulting comprehensive dataset, we intended to provide a source for further research in the field. We also conducted preliminary analyses of data focusing on occupations and regional distribution of malignant pleural mesothelioma cases.

METHODS: Data of asbestos-exposed individuals available from the Silag were anonymously linked with the SNC by means of deterministic record linkage. From this linkage, data on occupation classified according to the international standard classification of occupations (ISCO) as well as the canton of residence in Switzerland could be retrieved.

RESULTS: Of 838 eligible individuals from the Silag data, 788 (94.0%) could be linked to the SNC database, including 476 mesothelioma cases. In 340 cases of the latter, data on occupation and industries were available. Although the majority of them were blue-collar workers, a significant proportion (n = 44, 12.9%) had executive professions. The Canton of residence in 1990 was established in 430 of subjects with mesothelioma. A cluster could be identified in eastern Switzerland, especially in the canton of Glarus.

CONCLUSIONS: It was possible to link the datasets to a large extent thereby creating a data source for further research. Of note, the linkage provided data on occupation of a selection of mesothelioma cases in Switzerland.

References

  1. Collegium R ; Collegium Ramazzini. The 18th Collegium Ramazzini statement: the global health dimensions of asbestos and asbestos-related diseases. Scand J Work Environ Health. 2016 Jan;42(1):86–90. https://doi.org/10.5271/sjweh.3541
  2. Cancer Incidence in Switzerland. https://www.krebsregistrierung.ch/NicerReportFiles2018/EN/report/atlas.html [retrieved on 13 Nov. 2020]. NICER Foundation (National Institute for Cancer Epidemiology and Registration).
  3. Unfallstatistik UVG 2020. SUVA Luzern: Koordinationsgruppe für die Statistik der Unfallversicherung UVG (KSUV); 2020.
  4. Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005 Jul;366(9483):397–408. https://doi.org/10.1016/S0140-6736(05)67025-0
  5. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005 Oct;353(15):1591–603. https://doi.org/10.1056/NEJMra050152
  6. Unfallstatistik UVG 2019. SUVA Luzern: Koordinationsgruppe für die Statistik der Unfallversicherung UVG (KSUV); 2019.
  7. Bopp M, Spoerri A, Zwahlen M, Gutzwiller F, Paccaud F, Braun-Fahrländer C, et al. Cohort Profile: the Swiss National Cohort—a longitudinal study of 6.8 million people. Int J Epidemiol. 2009 Apr;38(2):379–84. https://doi.org/10.1093/ije/dyn042
  8. Bopp M, Braun J, Faeh D, Gutzwiller F ; Swiss National Cohort Study Group. Establishing a follow-up of the Swiss MONICA participants (1984-1993): record linkage with census and mortality data. BMC Public Health. 2010 Sep;10(1):562. https://doi.org/10.1186/1471-2458-10-562
  9. De Vuyst P, Karjalainen A, Dumortier P, Pairon JC, Monsó E, Brochard P, et al.; European Respiratory Society. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. Eur Respir J. 1998 Jun;11(6):1416–26. https://doi.org/10.1183/09031936.98.11061416
  10. Spoerri A, Zwahlen M, Egger M, Bopp M. The Swiss National Cohort: a unique database for national and international researchers. Int J Public Health. 2010 Aug;55(4):239–42. https://doi.org/10.1007/s00038-010-0160-5
  11. Nationales Institut für Krebsepidemiologie und –registrierung, NICER. https://www.nicer.org/ [retrieved on 24.01.2022]. NICER Foundation (National Institute for Cancer Epidemiology and Registration).
  12. Beeler PE, Meier SL, Bopp M, Dressel H. Datenquellen zur Häufigkeit des malignen Pleuramesothelioms in der Schweiz seit 2001. Arbeitsmedizin, Sozialmedizin. Umweltmedizin. 2021;56(9):567–73.
  13. Bopp M, Braun J, Faeh D, Egger M, Spoerri A, Zwahlen M, et al.; Swiss National Cohort Study Group. Variation in mortality patterns among the general population, study participants, and different types of nonparticipants: evidence from 25 years of follow-up. Am J Epidemiol. 2014 Nov;180(10):1028–35. https://doi.org/10.1093/aje/kwu226
  14. Die 4 Sprachgebiete der Schweiz nach Gemeinden: Bundesamt für Statistik; 2016.
  15. International Standard Classification of Occupations, version 1988 (ISCO-88). http://www.ilo.org/public/english/bureau/stat/isco/isco88/ [retrieved on 30 July 2020]. International Labour Organization (ILO); 1988.
  16. ISCO 88 (COM) (International Standard Classification of Occupations). https://www.bfs.admin.ch/bfs/de/home/statistiken/arbeit-erwerb/nomenclaturen/isco-88-com.assetdetail.4082545.html [last retrieved on 24 Jan 2022]. Bundesamt für Statistik; 2017.
  17. Meier U. Eidgenössische Volkszählung 1990: Verzeichnis der persönlichen Berufe. Bern: Bundesamt für Statistik; 1996.
  18. Doll R, Cook P. Summarizing indices for comparison of cancer incidence data. Int J Cancer. 1967 May;2(3):269–79. https://doi.org/10.1002/ijc.2910020310
  19. Data and methods. Cancer Incidence and Mortality in Switzerland by NICER. https://www.nicer.org/NicerReportFiles2015-2/EN/methods_file/methods.htm [retrieved on 15 Apr 2021]. NICER Foundation (National Institute for Cancer Epidemiology and Registration).
  20. Ruggeri G. Making a map of COVID-19 incidence in Switzerland using ggplot2 and sf. https://medium.com/epfl-extension-school/making-a-map-of-covid-19-incidence-in-switzerland-using-ggplot2-and-sf-e765f8ea0221 [retrieved on 24 Mar 2021]. 2020.
  21. Neumann V, Günthe S, Mülle KM, Fischer M. Malignant mesothelioma—german mesothelioma register 1987-1999. Int Arch Occup Environ Health. 2001 Aug;74(6):383–95. https://doi.org/10.1007/s004200100240
  22. NIOSH. 2017. Work-Related Lung Disease Surveillance System (eWoRLD). 2017-897, https://wwwn.cdc.gov/eWorld/Data/897 [retrieved on 30 July 2020]. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Respiratory Health Division, Morgantown, WV.
  23. Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Savès M, de Quillacq A, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med. 2006 Jun;63(6):390–5. https://doi.org/10.1136/oem.2005.023200
  24. Marinaccio A, Binazzi A, Marzio DD, Scarselli A, Verardo M, Mirabelli D, et al.; ReNaM Working Group. Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer. 2012 May;130(9):2146–54. https://doi.org/10.1002/ijc.26229
  25. Il registro nazionale dei Mesoteliomi - Sesto Rapporto. Milan: INAIL (Istituto nazionale per l'assicurazione contro gli infortuni sul lavoro); 2018.
  26. Janes SM, Alrifai D, Fennell DA. Perspectives on the Treatment of Malignant Pleural Mesothelioma. N Engl J Med. 2021 Sep;385(13):1207–18. https://doi.org/10.1056/NEJMra1912719
  27. Thomas A, Chen Y, Yu T, Gill A, Prasad V. Distinctive clinical characteristics of malignant mesothelioma in young patients. Oncotarget. 2015 Jun;6(18):16766–73. https://doi.org/10.18632/oncotarget.4414
  28. Galateau Salle F, Le Stang N, Nicholson AG, Pissaloux D, Churg A, Klebe S, et al. New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center. J Thorac Oncol. 2018 Aug;13(8):1189–203. https://doi.org/10.1016/j.jtho.2018.04.023
  29. Rolland P, Gramond C, Lacourt A, Astoul P, Chamming’s S, Ducamp S, et al.; PNSM Study Group. Occupations and industries in France at high risk for pleural mesothelioma: A population-based case-control study (1998-2002). Am J Ind Med. 2010 Dec;53(12):1207–19. https://doi.org/10.1002/ajim.20895
  30. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparén P, Tryggvadottir L, et al. Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48(5):646–790. https://doi.org/10.1080/02841860902913546
  31. Roelofs CR, Kernan GJ, Davis LK, Clapp RW, Hunt PR. Mesothelioma and employment in massachusetts: analysis of cancer registry data 1988-2003. Am J Ind Med. 2013 Sep;56(9):985–92. https://doi.org/10.1002/ajim.22218
  32. Müller KM, Dernbach AB, Neumann V. [Mesothelioma in academics. German Bochum mesothelioma register]. Chirurg. 2008 Mar; Suppl:99–102.
  33. Yeung P, Rogers A, Johnson A. Distribution of mesothelioma cases in different occupational groups and industries in Australia, 1979-1995. Appl Occup Environ Hyg. 1999 Nov;14(11):759–67. https://doi.org/10.1080/104732299302189
  34. Leigh J, Driscoll T. Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health. 2003 Jul-Sep;9(3):206–17. https://doi.org/10.1179/oeh.2003.9.3.206
  35. Mensi C, De Matteis S, Dallari B, Riboldi L, Bertazzi PA, Consonni D. Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections. Occup Environ Med. 2016 Sep;73(9):607–13. https://doi.org/10.1136/oemed-2016-103652
  36. Soberg MJ, van Zandwijk N. Incidence of malignant mesothelioma in New Zealand and Australia: a global snapshot. N Z Med J. 2015 Dec;128(1427):68–71.
  37. Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant Mesothelioma and Its Non-Asbestos Causes. Arch Pathol Lab Med. 2018 Jun;142(6):753–60. https://doi.org/10.5858/arpa.2017-0365-RA

Most read articles by the same author(s)

1 2 > >>